nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0369	0.158	CbGbCtD
Ziprasidone—CYP3A7—Dexamethasone—psoriatic arthritis	0.0369	0.158	CbGbCtD
Ziprasidone—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0285	0.122	CbGbCtD
Ziprasidone—CYP3A5—Dexamethasone—psoriatic arthritis	0.0277	0.119	CbGbCtD
Ziprasidone—CYP3A4—Triamcinolone—psoriatic arthritis	0.0216	0.0926	CbGbCtD
Ziprasidone—CYP3A4—Betamethasone—psoriatic arthritis	0.0186	0.0795	CbGbCtD
Ziprasidone—CYP3A4—Prednisolone—psoriatic arthritis	0.0183	0.0784	CbGbCtD
Ziprasidone—CYP3A4—Prednisone—psoriatic arthritis	0.0173	0.074	CbGbCtD
Ziprasidone—CYP2D6—Dexamethasone—psoriatic arthritis	0.017	0.0727	CbGbCtD
Ziprasidone—CYP3A4—Dexamethasone—psoriatic arthritis	0.0108	0.0462	CbGbCtD
Ziprasidone—Hypertension—Methylprednisolone—psoriatic arthritis	0.000701	0.000915	CcSEcCtD
Ziprasidone—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000699	0.000911	CcSEcCtD
Ziprasidone—Myalgia—Triamcinolone—psoriatic arthritis	0.000693	0.000904	CcSEcCtD
Ziprasidone—Pneumonia—Methotrexate—psoriatic arthritis	0.000692	0.000903	CcSEcCtD
Ziprasidone—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000692	0.000902	CcSEcCtD
Ziprasidone—Myalgia—Methylprednisolone—psoriatic arthritis	0.000692	0.000902	CcSEcCtD
Ziprasidone—Eye disorder—Prednisone—psoriatic arthritis	0.000691	0.000901	CcSEcCtD
Ziprasidone—Anxiety—Methylprednisolone—psoriatic arthritis	0.000689	0.000899	CcSEcCtD
Ziprasidone—Infestation NOS—Methotrexate—psoriatic arthritis	0.000688	0.000898	CcSEcCtD
Ziprasidone—Infestation—Methotrexate—psoriatic arthritis	0.000688	0.000898	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000687	0.000896	CcSEcCtD
Ziprasidone—Dry mouth—Triamcinolone—psoriatic arthritis	0.000678	0.000884	CcSEcCtD
Ziprasidone—Renal failure—Methotrexate—psoriatic arthritis	0.000676	0.000882	CcSEcCtD
Ziprasidone—Angioedema—Dexamethasone—psoriatic arthritis	0.000675	0.000881	CcSEcCtD
Ziprasidone—Angioedema—Betamethasone—psoriatic arthritis	0.000675	0.000881	CcSEcCtD
Ziprasidone—Angiopathy—Prednisone—psoriatic arthritis	0.000671	0.000875	CcSEcCtD
Ziprasidone—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000669	0.000873	CcSEcCtD
Ziprasidone—Confusional state—Methylprednisolone—psoriatic arthritis	0.000669	0.000872	CcSEcCtD
Ziprasidone—Immune system disorder—Prednisone—psoriatic arthritis	0.000668	0.000871	CcSEcCtD
Ziprasidone—Vertigo—Betamethasone—psoriatic arthritis	0.000664	0.000866	CcSEcCtD
Ziprasidone—Vertigo—Dexamethasone—psoriatic arthritis	0.000664	0.000866	CcSEcCtD
Ziprasidone—Syncope—Dexamethasone—psoriatic arthritis	0.000663	0.000864	CcSEcCtD
Ziprasidone—Syncope—Betamethasone—psoriatic arthritis	0.000663	0.000864	CcSEcCtD
Ziprasidone—Arrhythmia—Prednisone—psoriatic arthritis	0.00066	0.000861	CcSEcCtD
Ziprasidone—Infection—Triamcinolone—psoriatic arthritis	0.00066	0.000861	CcSEcCtD
Ziprasidone—Sweating—Methotrexate—psoriatic arthritis	0.00066	0.000861	CcSEcCtD
Ziprasidone—Infection—Methylprednisolone—psoriatic arthritis	0.000659	0.000859	CcSEcCtD
Ziprasidone—Haematuria—Methotrexate—psoriatic arthritis	0.000656	0.000856	CcSEcCtD
Ziprasidone—Shock—Triamcinolone—psoriatic arthritis	0.000654	0.000853	CcSEcCtD
Ziprasidone—Insomnia—Prednisolone—psoriatic arthritis	0.000654	0.000853	CcSEcCtD
Ziprasidone—Alopecia—Prednisone—psoriatic arthritis	0.000653	0.000852	CcSEcCtD
Ziprasidone—Shock—Methylprednisolone—psoriatic arthritis	0.000652	0.000851	CcSEcCtD
Ziprasidone—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00065	0.000848	CcSEcCtD
Ziprasidone—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000649	0.000847	CcSEcCtD
Ziprasidone—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000649	0.000847	CcSEcCtD
Ziprasidone—Epistaxis—Methotrexate—psoriatic arthritis	0.000649	0.000847	CcSEcCtD
Ziprasidone—Paraesthesia—Prednisolone—psoriatic arthritis	0.000649	0.000847	CcSEcCtD
Ziprasidone—Tachycardia—Triamcinolone—psoriatic arthritis	0.000649	0.000846	CcSEcCtD
Ziprasidone—Mental disorder—Prednisone—psoriatic arthritis	0.000647	0.000845	CcSEcCtD
Ziprasidone—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000647	0.000844	CcSEcCtD
Ziprasidone—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000644	0.00084	CcSEcCtD
Ziprasidone—Malnutrition—Prednisone—psoriatic arthritis	0.000643	0.000839	CcSEcCtD
Ziprasidone—Erythema—Prednisone—psoriatic arthritis	0.000643	0.000839	CcSEcCtD
Ziprasidone—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000642	0.000838	CcSEcCtD
Ziprasidone—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000641	0.000836	CcSEcCtD
Ziprasidone—Hypertension—Betamethasone—psoriatic arthritis	0.000638	0.000832	CcSEcCtD
Ziprasidone—Hypertension—Dexamethasone—psoriatic arthritis	0.000638	0.000832	CcSEcCtD
Ziprasidone—Myalgia—Betamethasone—psoriatic arthritis	0.000629	0.000821	CcSEcCtD
Ziprasidone—Myalgia—Dexamethasone—psoriatic arthritis	0.000629	0.000821	CcSEcCtD
Ziprasidone—Anxiety—Dexamethasone—psoriatic arthritis	0.000627	0.000818	CcSEcCtD
Ziprasidone—Anxiety—Betamethasone—psoriatic arthritis	0.000627	0.000818	CcSEcCtD
Ziprasidone—Haemoglobin—Methotrexate—psoriatic arthritis	0.000621	0.00081	CcSEcCtD
Ziprasidone—Hypotension—Methylprednisolone—psoriatic arthritis	0.00062	0.000808	CcSEcCtD
Ziprasidone—Hepatitis—Methotrexate—psoriatic arthritis	0.000618	0.000806	CcSEcCtD
Ziprasidone—Haemorrhage—Methotrexate—psoriatic arthritis	0.000618	0.000806	CcSEcCtD
Ziprasidone—Pharyngitis—Methotrexate—psoriatic arthritis	0.000613	0.0008	CcSEcCtD
Ziprasidone—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00061	0.000796	CcSEcCtD
Ziprasidone—Vision blurred—Prednisone—psoriatic arthritis	0.000606	0.000791	CcSEcCtD
Ziprasidone—Urethral disorder—Methotrexate—psoriatic arthritis	0.000605	0.00079	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000605	0.00079	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000604	0.000788	CcSEcCtD
Ziprasidone—Insomnia—Triamcinolone—psoriatic arthritis	0.000601	0.000784	CcSEcCtD
Ziprasidone—Insomnia—Methylprednisolone—psoriatic arthritis	0.0006	0.000782	CcSEcCtD
Ziprasidone—Infection—Dexamethasone—psoriatic arthritis	0.000599	0.000782	CcSEcCtD
Ziprasidone—Infection—Betamethasone—psoriatic arthritis	0.000599	0.000782	CcSEcCtD
Ziprasidone—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000597	0.000778	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000595	0.000777	CcSEcCtD
Ziprasidone—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000595	0.000777	CcSEcCtD
Ziprasidone—Visual impairment—Methotrexate—psoriatic arthritis	0.000595	0.000777	CcSEcCtD
Ziprasidone—Anaemia—Prednisone—psoriatic arthritis	0.000595	0.000776	CcSEcCtD
Ziprasidone—Shock—Betamethasone—psoriatic arthritis	0.000593	0.000774	CcSEcCtD
Ziprasidone—Shock—Dexamethasone—psoriatic arthritis	0.000593	0.000774	CcSEcCtD
Ziprasidone—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000592	0.000773	CcSEcCtD
Ziprasidone—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000591	0.000771	CcSEcCtD
Ziprasidone—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000591	0.000771	CcSEcCtD
Ziprasidone—Agitation—Prednisone—psoriatic arthritis	0.000591	0.000771	CcSEcCtD
Ziprasidone—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00059	0.00077	CcSEcCtD
Ziprasidone—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00059	0.00077	CcSEcCtD
Ziprasidone—Tachycardia—Betamethasone—psoriatic arthritis	0.000588	0.000768	CcSEcCtD
Ziprasidone—Tachycardia—Dexamethasone—psoriatic arthritis	0.000588	0.000768	CcSEcCtD
Ziprasidone—Angioedema—Prednisone—psoriatic arthritis	0.000588	0.000767	CcSEcCtD
Ziprasidone—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000585	0.000763	CcSEcCtD
Ziprasidone—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000584	0.000761	CcSEcCtD
Ziprasidone—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000583	0.00076	CcSEcCtD
Ziprasidone—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000583	0.00076	CcSEcCtD
Ziprasidone—Vertigo—Prednisone—psoriatic arthritis	0.000578	0.000754	CcSEcCtD
Ziprasidone—Eye disorder—Methotrexate—psoriatic arthritis	0.000577	0.000753	CcSEcCtD
Ziprasidone—Syncope—Prednisone—psoriatic arthritis	0.000577	0.000753	CcSEcCtD
Ziprasidone—Tinnitus—Methotrexate—psoriatic arthritis	0.000576	0.000751	CcSEcCtD
Ziprasidone—Anorexia—Betamethasone—psoriatic arthritis	0.000575	0.00075	CcSEcCtD
Ziprasidone—Anorexia—Dexamethasone—psoriatic arthritis	0.000575	0.00075	CcSEcCtD
Ziprasidone—Urticaria—Prednisolone—psoriatic arthritis	0.000574	0.000749	CcSEcCtD
Ziprasidone—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000573	0.000748	CcSEcCtD
Ziprasidone—Fatigue—Triamcinolone—psoriatic arthritis	0.000573	0.000747	CcSEcCtD
Ziprasidone—Fatigue—Methylprednisolone—psoriatic arthritis	0.000572	0.000746	CcSEcCtD
Ziprasidone—Loss of consciousness—Prednisone—psoriatic arthritis	0.000565	0.000738	CcSEcCtD
Ziprasidone—Hypotension—Dexamethasone—psoriatic arthritis	0.000563	0.000735	CcSEcCtD
Ziprasidone—Hypotension—Betamethasone—psoriatic arthritis	0.000563	0.000735	CcSEcCtD
Ziprasidone—Angiopathy—Methotrexate—psoriatic arthritis	0.00056	0.000731	CcSEcCtD
Ziprasidone—Immune system disorder—Methotrexate—psoriatic arthritis	0.000558	0.000728	CcSEcCtD
Ziprasidone—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000557	0.000726	CcSEcCtD
Ziprasidone—Hypertension—Prednisone—psoriatic arthritis	0.000555	0.000725	CcSEcCtD
Ziprasidone—Chills—Methotrexate—psoriatic arthritis	0.000554	0.000723	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000549	0.000717	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000549	0.000717	CcSEcCtD
Ziprasidone—Arthralgia—Prednisone—psoriatic arthritis	0.000548	0.000715	CcSEcCtD
Ziprasidone—Myalgia—Prednisone—psoriatic arthritis	0.000548	0.000715	CcSEcCtD
Ziprasidone—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000548	0.000714	CcSEcCtD
Ziprasidone—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000546	0.000713	CcSEcCtD
Ziprasidone—Anxiety—Prednisone—psoriatic arthritis	0.000546	0.000712	CcSEcCtD
Ziprasidone—Alopecia—Methotrexate—psoriatic arthritis	0.000546	0.000712	CcSEcCtD
Ziprasidone—Insomnia—Betamethasone—psoriatic arthritis	0.000545	0.000711	CcSEcCtD
Ziprasidone—Insomnia—Dexamethasone—psoriatic arthritis	0.000545	0.000711	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000544	0.00071	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000542	0.000707	CcSEcCtD
Ziprasidone—Paraesthesia—Betamethasone—psoriatic arthritis	0.000541	0.000706	CcSEcCtD
Ziprasidone—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000541	0.000706	CcSEcCtD
Ziprasidone—Mental disorder—Methotrexate—psoriatic arthritis	0.000541	0.000706	CcSEcCtD
Ziprasidone—Malnutrition—Methotrexate—psoriatic arthritis	0.000538	0.000702	CcSEcCtD
Ziprasidone—Erythema—Methotrexate—psoriatic arthritis	0.000538	0.000702	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000532	0.000695	CcSEcCtD
Ziprasidone—Dyspepsia—Betamethasone—psoriatic arthritis	0.000531	0.000692	CcSEcCtD
Ziprasidone—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000531	0.000692	CcSEcCtD
Ziprasidone—Urticaria—Triamcinolone—psoriatic arthritis	0.000528	0.000689	CcSEcCtD
Ziprasidone—Urticaria—Methylprednisolone—psoriatic arthritis	0.000527	0.000687	CcSEcCtD
Ziprasidone—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000525	0.000685	CcSEcCtD
Ziprasidone—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000524	0.000684	CcSEcCtD
Ziprasidone—Decreased appetite—Betamethasone—psoriatic arthritis	0.000524	0.000684	CcSEcCtD
Ziprasidone—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000524	0.000684	CcSEcCtD
Ziprasidone—Infection—Prednisone—psoriatic arthritis	0.000522	0.000681	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000521	0.000679	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000521	0.000679	CcSEcCtD
Ziprasidone—Back pain—Methotrexate—psoriatic arthritis	0.00052	0.000679	CcSEcCtD
Ziprasidone—Fatigue—Dexamethasone—psoriatic arthritis	0.00052	0.000678	CcSEcCtD
Ziprasidone—Fatigue—Betamethasone—psoriatic arthritis	0.00052	0.000678	CcSEcCtD
Ziprasidone—Shock—Prednisone—psoriatic arthritis	0.000517	0.000674	CcSEcCtD
Ziprasidone—Nervous system disorder—Prednisone—psoriatic arthritis	0.000515	0.000672	CcSEcCtD
Ziprasidone—Tachycardia—Prednisone—psoriatic arthritis	0.000512	0.000669	CcSEcCtD
Ziprasidone—Skin disorder—Prednisone—psoriatic arthritis	0.00051	0.000665	CcSEcCtD
Ziprasidone—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000508	0.000662	CcSEcCtD
Ziprasidone—Vision blurred—Methotrexate—psoriatic arthritis	0.000507	0.000661	CcSEcCtD
Ziprasidone—Anorexia—Prednisone—psoriatic arthritis	0.000501	0.000653	CcSEcCtD
Ziprasidone—Anaemia—Methotrexate—psoriatic arthritis	0.000497	0.000648	CcSEcCtD
Ziprasidone—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000497	0.000648	CcSEcCtD
Ziprasidone—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000497	0.000648	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000493	0.000643	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000493	0.000643	CcSEcCtD
Ziprasidone—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00049	0.000639	CcSEcCtD
Ziprasidone—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000488	0.000637	CcSEcCtD
Ziprasidone—Vertigo—Methotrexate—psoriatic arthritis	0.000483	0.00063	CcSEcCtD
Ziprasidone—Leukopenia—Methotrexate—psoriatic arthritis	0.000481	0.000628	CcSEcCtD
Ziprasidone—Urticaria—Betamethasone—psoriatic arthritis	0.000479	0.000625	CcSEcCtD
Ziprasidone—Urticaria—Dexamethasone—psoriatic arthritis	0.000479	0.000625	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000478	0.000624	CcSEcCtD
Ziprasidone—Dizziness—Prednisolone—psoriatic arthritis	0.000478	0.000623	CcSEcCtD
Ziprasidone—Asthenia—Triamcinolone—psoriatic arthritis	0.000477	0.000622	CcSEcCtD
Ziprasidone—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000477	0.000622	CcSEcCtD
Ziprasidone—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000477	0.000622	CcSEcCtD
Ziprasidone—Abdominal pain—Betamethasone—psoriatic arthritis	0.000477	0.000622	CcSEcCtD
Ziprasidone—Body temperature increased—Betamethasone—psoriatic arthritis	0.000477	0.000622	CcSEcCtD
Ziprasidone—Asthenia—Methylprednisolone—psoriatic arthritis	0.000476	0.000621	CcSEcCtD
Ziprasidone—Insomnia—Prednisone—psoriatic arthritis	0.000475	0.00062	CcSEcCtD
Ziprasidone—Paraesthesia—Prednisone—psoriatic arthritis	0.000471	0.000615	CcSEcCtD
Ziprasidone—Cough—Methotrexate—psoriatic arthritis	0.000469	0.000612	CcSEcCtD
Ziprasidone—Dyspepsia—Prednisone—psoriatic arthritis	0.000462	0.000603	CcSEcCtD
Ziprasidone—Chest pain—Methotrexate—psoriatic arthritis	0.000458	0.000597	CcSEcCtD
Ziprasidone—Myalgia—Methotrexate—psoriatic arthritis	0.000458	0.000597	CcSEcCtD
Ziprasidone—Arthralgia—Methotrexate—psoriatic arthritis	0.000458	0.000597	CcSEcCtD
Ziprasidone—Decreased appetite—Prednisone—psoriatic arthritis	0.000456	0.000596	CcSEcCtD
Ziprasidone—Rash—Prednisolone—psoriatic arthritis	0.000456	0.000594	CcSEcCtD
Ziprasidone—Dermatitis—Prednisolone—psoriatic arthritis	0.000455	0.000594	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000455	0.000593	CcSEcCtD
Ziprasidone—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000454	0.000592	CcSEcCtD
Ziprasidone—Fatigue—Prednisone—psoriatic arthritis	0.000453	0.000591	CcSEcCtD
Ziprasidone—Headache—Prednisolone—psoriatic arthritis	0.000453	0.000591	CcSEcCtD
Ziprasidone—Constipation—Prednisone—psoriatic arthritis	0.000449	0.000586	CcSEcCtD
Ziprasidone—Confusional state—Methotrexate—psoriatic arthritis	0.000442	0.000577	CcSEcCtD
Ziprasidone—Dizziness—Triamcinolone—psoriatic arthritis	0.000439	0.000573	CcSEcCtD
Ziprasidone—Dizziness—Methylprednisolone—psoriatic arthritis	0.000438	0.000572	CcSEcCtD
Ziprasidone—Infection—Methotrexate—psoriatic arthritis	0.000436	0.000569	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisone—psoriatic arthritis	0.000433	0.000565	CcSEcCtD
Ziprasidone—Asthenia—Dexamethasone—psoriatic arthritis	0.000433	0.000564	CcSEcCtD
Ziprasidone—Asthenia—Betamethasone—psoriatic arthritis	0.000433	0.000564	CcSEcCtD
Ziprasidone—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00043	0.000561	CcSEcCtD
Ziprasidone—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00043	0.000561	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000429	0.00056	CcSEcCtD
Ziprasidone—Nausea—Prednisolone—psoriatic arthritis	0.000429	0.00056	CcSEcCtD
Ziprasidone—Skin disorder—Methotrexate—psoriatic arthritis	0.000426	0.000556	CcSEcCtD
Ziprasidone—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000424	0.000553	CcSEcCtD
Ziprasidone—Vomiting—Triamcinolone—psoriatic arthritis	0.000422	0.000551	CcSEcCtD
Ziprasidone—Vomiting—Methylprednisolone—psoriatic arthritis	0.000422	0.00055	CcSEcCtD
Ziprasidone—Rash—Triamcinolone—psoriatic arthritis	0.000419	0.000547	CcSEcCtD
Ziprasidone—Dermatitis—Triamcinolone—psoriatic arthritis	0.000419	0.000546	CcSEcCtD
Ziprasidone—Anorexia—Methotrexate—psoriatic arthritis	0.000418	0.000546	CcSEcCtD
Ziprasidone—Rash—Methylprednisolone—psoriatic arthritis	0.000418	0.000545	CcSEcCtD
Ziprasidone—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000418	0.000545	CcSEcCtD
Ziprasidone—Urticaria—Prednisone—psoriatic arthritis	0.000417	0.000544	CcSEcCtD
Ziprasidone—Headache—Triamcinolone—psoriatic arthritis	0.000416	0.000543	CcSEcCtD
Ziprasidone—Headache—Methylprednisolone—psoriatic arthritis	0.000415	0.000542	CcSEcCtD
Ziprasidone—Body temperature increased—Prednisone—psoriatic arthritis	0.000415	0.000542	CcSEcCtD
Ziprasidone—Abdominal pain—Prednisone—psoriatic arthritis	0.000415	0.000542	CcSEcCtD
Ziprasidone—Diarrhoea—Betamethasone—psoriatic arthritis	0.000413	0.000538	CcSEcCtD
Ziprasidone—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000413	0.000538	CcSEcCtD
Ziprasidone—Hypotension—Methotrexate—psoriatic arthritis	0.00041	0.000535	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.0004	0.000522	CcSEcCtD
Ziprasidone—Dizziness—Dexamethasone—psoriatic arthritis	0.000399	0.00052	CcSEcCtD
Ziprasidone—Dizziness—Betamethasone—psoriatic arthritis	0.000399	0.00052	CcSEcCtD
Ziprasidone—Insomnia—Methotrexate—psoriatic arthritis	0.000397	0.000518	CcSEcCtD
Ziprasidone—Nausea—Triamcinolone—psoriatic arthritis	0.000395	0.000515	CcSEcCtD
Ziprasidone—Paraesthesia—Methotrexate—psoriatic arthritis	0.000394	0.000514	CcSEcCtD
Ziprasidone—Nausea—Methylprednisolone—psoriatic arthritis	0.000394	0.000514	CcSEcCtD
Ziprasidone—Dyspnoea—Methotrexate—psoriatic arthritis	0.000391	0.00051	CcSEcCtD
Ziprasidone—Somnolence—Methotrexate—psoriatic arthritis	0.00039	0.000509	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisone—psoriatic arthritis	0.000387	0.000505	CcSEcCtD
Ziprasidone—Dyspepsia—Methotrexate—psoriatic arthritis	0.000386	0.000504	CcSEcCtD
Ziprasidone—Vomiting—Betamethasone—psoriatic arthritis	0.000383	0.0005	CcSEcCtD
Ziprasidone—Vomiting—Dexamethasone—psoriatic arthritis	0.000383	0.0005	CcSEcCtD
Ziprasidone—Decreased appetite—Methotrexate—psoriatic arthritis	0.000381	0.000498	CcSEcCtD
Ziprasidone—Rash—Dexamethasone—psoriatic arthritis	0.00038	0.000496	CcSEcCtD
Ziprasidone—Rash—Betamethasone—psoriatic arthritis	0.00038	0.000496	CcSEcCtD
Ziprasidone—Dermatitis—Betamethasone—psoriatic arthritis	0.00038	0.000496	CcSEcCtD
Ziprasidone—Dermatitis—Dexamethasone—psoriatic arthritis	0.00038	0.000496	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000379	0.000494	CcSEcCtD
Ziprasidone—Fatigue—Methotrexate—psoriatic arthritis	0.000378	0.000494	CcSEcCtD
Ziprasidone—Headache—Dexamethasone—psoriatic arthritis	0.000378	0.000493	CcSEcCtD
Ziprasidone—Headache—Betamethasone—psoriatic arthritis	0.000378	0.000493	CcSEcCtD
Ziprasidone—Asthenia—Prednisone—psoriatic arthritis	0.000377	0.000492	CcSEcCtD
Ziprasidone—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000362	0.000472	CcSEcCtD
Ziprasidone—Diarrhoea—Prednisone—psoriatic arthritis	0.000359	0.000469	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000359	0.000468	CcSEcCtD
Ziprasidone—Nausea—Dexamethasone—psoriatic arthritis	0.000358	0.000467	CcSEcCtD
Ziprasidone—Nausea—Betamethasone—psoriatic arthritis	0.000358	0.000467	CcSEcCtD
Ziprasidone—Urticaria—Methotrexate—psoriatic arthritis	0.000349	0.000455	CcSEcCtD
Ziprasidone—Dizziness—Prednisone—psoriatic arthritis	0.000347	0.000453	CcSEcCtD
Ziprasidone—Abdominal pain—Methotrexate—psoriatic arthritis	0.000347	0.000453	CcSEcCtD
Ziprasidone—Body temperature increased—Methotrexate—psoriatic arthritis	0.000347	0.000453	CcSEcCtD
Ziprasidone—Vomiting—Prednisone—psoriatic arthritis	0.000334	0.000436	CcSEcCtD
Ziprasidone—Rash—Prednisone—psoriatic arthritis	0.000331	0.000432	CcSEcCtD
Ziprasidone—Dermatitis—Prednisone—psoriatic arthritis	0.000331	0.000432	CcSEcCtD
Ziprasidone—Headache—Prednisone—psoriatic arthritis	0.000329	0.000429	CcSEcCtD
Ziprasidone—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000323	0.000422	CcSEcCtD
Ziprasidone—Asthenia—Methotrexate—psoriatic arthritis	0.000315	0.000411	CcSEcCtD
Ziprasidone—Nausea—Prednisone—psoriatic arthritis	0.000312	0.000407	CcSEcCtD
Ziprasidone—Diarrhoea—Methotrexate—psoriatic arthritis	0.0003	0.000392	CcSEcCtD
Ziprasidone—Dizziness—Methotrexate—psoriatic arthritis	0.00029	0.000379	CcSEcCtD
Ziprasidone—Vomiting—Methotrexate—psoriatic arthritis	0.000279	0.000364	CcSEcCtD
Ziprasidone—Rash—Methotrexate—psoriatic arthritis	0.000277	0.000361	CcSEcCtD
Ziprasidone—Dermatitis—Methotrexate—psoriatic arthritis	0.000276	0.000361	CcSEcCtD
Ziprasidone—Headache—Methotrexate—psoriatic arthritis	0.000275	0.000359	CcSEcCtD
Ziprasidone—Nausea—Methotrexate—psoriatic arthritis	0.000261	0.00034	CcSEcCtD
